U.S. Patented Skin Cell Spray Technology: Clinically Validated, is Available for Immediate Acquisition by Strategic Buyers in Wound Care or Regenerative Medicine
Summary by WV News
6 Articles
6 Articles
All
Left
Center
2
Right
U.S. Patented Skin Cell Spray Technology: Clinically Validated, is Available for Immediate Acquisition by Strategic Buyers in Wound Care or Regenerative Medicine
TUCSON, Ariz., May 28, 2025 /PRNewswire/ -- DermaWound, a pioneering wound care company founded by renowned physician and inventor David M. Dixon MD, is announcing the exclusive sale of its issued U.S. patent covering a revolutionary Skin Cell Spraying Device…
Coverage Details
Total News Sources6
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage